Founded Year

2013

Stage

Incubator/Accelerator | Alive

Total Raised

$50M

About Medial EarlySign

Medial EarlySign helps healthcare systems with their early detection and prevention of high-burden diseases and chronic medical conditions. The outcome-focused clinical software solutions (AlgoMarkers) find subtle, early signs of high-risk patient trajectories in existing lab results and ordinary EHR data already collected in the course of routine care. The company was founded in 2013 and is based in Israel.

Medial EarlySign Headquarter Location

Hanager 6 Suite 300

Hod Hasharon, 4527703,

Israel

+972 72 240 8777

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Medial EarlySign's Products & Differentiation

See Medial EarlySign's products and how their products differentiate from alternatives and competitors

  • AlgoAnalyzer

    EarlySign’s AlgoAnalyzer is a server-side software platform for running various healthcare calculators, including patient-specific algorithmic and predictive models called AlgoMarkers™.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

Expert Collections containing Medial EarlySign

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Medial EarlySign is included in 5 Expert Collections, including Artificial Intelligence.

A

Artificial Intelligence

9,051 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.

M

Medical Devices

8,378 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

C

Conference Exhibitors

5,302 items

D

Digital Health

13,075 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

H

Health IT

10,180 items

This collection includes public and private companies, as well as startups, that market software solutions to healthcare provider organizations.

Latest Medial EarlySign News

Datos Health Partners With Medial EarlySign, Augments Artificial Intelligence With Remote Care Automation To Optimize Patient Care

Mar 11, 2021

Share Collaboration will Provide Healthcare Organizations an End-to-End Solution for Early Identification and Improved Care for High-Risk Populations Datos Health , a leader in remote care automation , and Medial EarlySign , an innovator in AI-based actionable clinical insights , announced  a collaboration to offer state-of-the-art integrated solutions to identify high-risk patients who stand to benefit from remote care programs. The solution is focused on helping providers achieve better outcomes in vulnerable populations, as they transition to value-based care. The collaboration combines EarlySign’s predictive solutions for identifying patients at increased risk of specific chronic or life-threatening conditions with Datos’ corresponding automated remote care programs, helping to prevent or delay the onset of disease and downstream complications. The introduction of this solution is particularly crucial as high-risk population management becomes a must-have competency for healthcare providers of all denominations, with organizations striving to deliver better preventive services across the care continuum. Related Posts “The transition to value-based care and pre-emptive approaches requires deeper insight into the patient population. Medial EarlySign’s AI-based clinical approach facilitates proactive and preventative treatment through earlier identification of high-risk patient trajectories when interventions stand more chance of halting or preventing the onset of disease,” said  Ori Geva , CEO and Co-Founder of Medial EarlySign. “Datos provides healthcare stakeholders new options and models of intervention for these high-risk patients, including a way to seamlessly enable more frequent, or even continuous monitoring and engagement that can reduce intervention costs and significantly improve care delivery and patient outcomes. “Datos has spent the last several years focused on building a solution for personalized and automated remote care across a diverse range of disease conditions, enabling better care and a higher level of patient engagement and participation,” said Uri Bettesh , CEO and Founder of Datos Health. “The prospect of extending automated remote care to pre-disease and early onset stages opens up a new world of possibilities for the ultimate goal of keeping people healthier for longer.”

Medial EarlySign Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Medial EarlySign Rank

  • When was Medial EarlySign founded?

    Medial EarlySign was founded in 2013.

  • Where is Medial EarlySign's headquarters?

    Medial EarlySign's headquarters is located at Hanager 6, Hod Hasharon.

  • What is Medial EarlySign's latest funding round?

    Medial EarlySign's latest funding round is Incubator/Accelerator.

  • How much did Medial EarlySign raise?

    Medial EarlySign raised a total of $50M.

  • Who are the investors of Medial EarlySign?

    Investors of Medial EarlySign include PlayBeyondBio, Horizon Ventures, aMoon Fund, Nir Kalkstein and Marius Nacht Life Sciences Fund.

  • Who are Medial EarlySign's competitors?

    Competitors of Medial EarlySign include KenSci and 4 more.

  • What products does Medial EarlySign offer?

    Medial EarlySign's products include AlgoAnalyzer and 2 more.

  • Who are Medial EarlySign's customers?

    Customers of Medial EarlySign include Geisinger HealthSystem, Northwest Permanente and Geisinger.

You May Also Like

ClosedLoop.ai Logo
ClosedLoop.ai

ClosedLoop.ai is an artificial intelligence-based precision health platform that allows users to do three things: integrate data from a variety of disparate sources (Claims, EHR, Genomic, Wearable, Environmental, Social), create AI models to predict health outcomes and support clinical decisions optimized for individual patients, and monitor and aggregate the impact of interventions over time to make the best decision for the next patient.

Prealize Logo
Prealize

Prealize uses machine learning to responsibly contain health care spending for patients and their health insurers by predicting those who will be high-cost patients in the coming year.

E
Epic

Epic specializes in the development of software for healthcare organizations.

Pecan AI Logo
Pecan AI

Pecan AI is a deep learning platform that automatically generates business intelligence predictions for companies and organizations.

Skytree Logo
Skytree

Skytree - The Machine Learning Company, offers Advanced Analytics market with a Machine Learning platform that gives organizations the power to discover deep analytic insights, predict future trends, make recommendations and reveal untapped markets and customers. Skytree's flagship product - Skytree Server - is a general purpose scalable Machine Learning system built for the highest accuracy at unprecedented speed and scale.

M
Metaspectral

Metaspectral derives real-time insights from artificial intelligence (AI) using “ultra-high-resolution, visible-to-infrared (hyperspectral) imagery.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.